Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, September 30, 2014 ) Dallas, TX -- Researcher’s clinical trial report, “Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2014″ provides data on the Ischemic Cardiomyopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ischemic Cardiomyopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ischemic Cardiomyopathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Researcher’s team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=214297 .
Scope
• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=214297 . (Report Price: Single User License – US$ 2500 and Corporate User License – US$ 7500)
Table of Contents
Table of Contents 2
List of Tables4
List of Figures 5
Introduction 6
Ischemic Cardiomyopathy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Ischemic Cardiomyopathy to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Ischemic Cardiomyopathy to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Ischemic Cardiomyopathy 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Ischemic Cardiomyopathy Therapeutics Clinical Trials 29
Prominent Drugs 31
Latest Clinical Trials News on Ischemic Cardiomyopathy 32
Aug 22, 2014: Treatment With Aastrom's Ixmyelocel-T Shown to Reduce Incidence of Major Adverse Cardiovascular Events in Patients With Ischemic Dilated Cardiomyopathy 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Celladon Corporation 33
Clinical Trial Overview of Celladon Corporation 33
Medtronic CardioVascular, Inc. 34
Clinical Trial Overview of Medtronic CardioVascular, Inc. 34
Medistem, Inc. 35
Clinical Trial Overview of Medistem, Inc. 35
Kolding Sygehus 36
Clinical Trial Overview of Kolding Sygehus 36
Johnson & Johnson 37
Clinical Trial Overview of Johnson & Johnson 37
Bioheart, Inc. 38
Clinical Trial Overview of Bioheart, Inc. 38
Ajanta Pharma Limited 39
Clinical Trial Overview of Ajanta Pharma Limited 39
Advanced Cell Technology, Inc. 40
About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
RnR Market Research
Ritesh Tiwari
+ 1-888-391-5441
sales@rnrmarketresearch.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|